Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events
Garvan Institute of Medical Research · The Kinghorn Cancer Centre · +5 more institutions
Abstract
Entry and progression through mitosis has traditionally been linked directly to the activity of cyclin-dependent kinase 1 (Cdk1). In this study we utilized low doses of the Cdk1-specific inhibitor, RO3306 from early G 2 phase onwards. Addition of low doses of RO3306 in G 2 phase induced minor chromosome congression and segregation defects. In contrast, mild doses of RO3306 during G 2 phase resulted in cells entering an aberrant mitosis, with cells fragmenting centrosomes and failing to fully disassemble the nuclear envelope. Cells often underwent cytokinesis and metaphase simultaneously, despite the presence of an active spindle assembly checkpoint, which prevented degradation of cyclin B1 and securin,…
Citation impact
- FWCI
- 36.23
- Percentile
- 100%
- References
- 49
Authors
6- RARachael A. McCloy
Garvan Institute of Medical Research, The Kinghorn Cancer Centre
- SRSamuel Rogers
Garvan Institute of Medical Research, The Kinghorn Cancer Centre
- CEC. Elizabeth Caldon
Garvan Institute of Medical Research, Faculty (United Kingdom), St Vincent's Clinic, The Kinghorn Cancer Centre
- TLThierry Lorca
Centre National de la Recherche Scientifique, Université de Montpellier, Centre de Recherche en Biologie cellulaire de Montpellier
- ACAnna Castro
Centre National de la Recherche Scientifique, Université de Montpellier, Centre de Recherche en Biologie cellulaire de Montpellier
Topics & keywords
- Mitosis
- Biology
- Cell biology
- Metaphase
- Cyclin B1
- Maturation promoting factor
- Cyclin-dependent kinase 1
- Mitotic exit